These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 31166523)

  • 1. Risk factors for cardiovascular disease in HIV/AIDS patients treated with highly active antiretroviral therapy (HAART) in the central-southern region of the state of Paraná - Brazil.
    Muller EV; Gimeno SGA
    Cien Saude Colet; 2019 May; 24(5):1903-1914. PubMed ID: 31166523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of antiretroviral choice on hypercholesterolaemia events: the role of the nucleoside reverse transcriptase inhibitor backbone.
    Jones R; Sawleshwarkar S; Michailidis C; Jackson A; Mandalia S; Stebbing J; Bower M; Nelson M; Gazzard BG; Moyle GJ
    HIV Med; 2005 Nov; 6(6):396-402. PubMed ID: 16268821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum lipids and glucose abnormalities in HIV/AIDS patients on antiretroviral therapies.
    Salami AK; Akande AA; Olokoba AB
    West Afr J Med; 2009 Jan; 28(1):10-5. PubMed ID: 19662738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic effects associated to the highly active antiretroviral therapy (HAART) in AIDS patients.
    Domingos H; Cunha RV; Paniago AM; Martins DM; Elkhoury EB; Souza AS
    Braz J Infect Dis; 2009 Apr; 13(2):130-6. PubMed ID: 20140358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiometabolic risk among HIV-POSITIVE Ugandan adults: prevalence, predictors and effect of long-term antiretroviral therapy.
    Kazooba P; Kasamba I; Mayanja BN; Lutaakome J; Namakoola I; Salome T; Kaleebu P; Munderi P
    Pan Afr Med J; 2017; 27():40. PubMed ID: 28761616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid profile, cardiovascular risk factors and metabolic syndrome in a group of AIDS patients.
    Silva EF; Bassichetto KC; Lewi DS
    Arq Bras Cardiol; 2009 Aug; 93(2):113-8. PubMed ID: 19838487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of metabolic complications and cardiovascular risk in HIV-infected patients.
    Blanco F; San Román J; Vispo E; López M; Salto A; Abad V; Soriano V
    AIDS Rev; 2010; 12(4):231-41. PubMed ID: 21179187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of antiretroviral treatment and nadir CD4 count in progression to cardiovascular events and related comorbidities in a HIV Brazilian cohort: a multi-stage approach.
    Oliveira RVC; Shimakura SE; Campos DP; Hökerberg YHM; Victoriano FP; Ribeiro S; Veloso VG; Grinsztejn B; Carvalho MS
    AIDS Care; 2018 May; 30(5):551-559. PubMed ID: 29058481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study.
    Friis-Møller N; Weber R; Reiss P; Thiébaut R; Kirk O; d'Arminio Monforte A; Pradier C; Morfeldt L; Mateu S; Law M; El-Sadr W; De Wit S; Sabin CA; Phillips AN; Lundgren JD;
    AIDS; 2003 May; 17(8):1179-93. PubMed ID: 12819520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum lipid levels associated with increased risk for cardiovascular disease is associated with highly active antiretroviral therapy (HAART) in HIV-1 infection.
    Koppel K; Bratt G; Eriksson M; Sandström E
    Int J STD AIDS; 2000 Jul; 11(7):451-5. PubMed ID: 10919487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substituting abacavir for hyperlipidemia-associated protease inhibitors in HAART regimens improves fasting lipid profiles, maintains virologic suppression, and simplifies treatment.
    Keiser PH; Sension MG; DeJesus E; Rodriguez A; Olliffe JF; Williams VC; Wakeford JH; Snidow JW; Shachoy-Clark AD; Fleming JW; Pakes GE; Hernandez JE;
    BMC Infect Dis; 2005 Jan; 5():2. PubMed ID: 15647105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid-lowering efficacy and safety after switching to atazanavir-ritonavir-based highly active antiretroviral therapy in patients with human immunodeficiency virus.
    Nguyen ST; Eaton SA; Bain AM; Rahman AP; Payne KD; Bedimo R; Herrington JD; Maclayton DO; Rodriguez-Barradas MC; Busti AJ
    Pharmacotherapy; 2008 Mar; 28(3):323-30. PubMed ID: 18294112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cardiovascular risk factors associated with antiretroviral therapy].
    Pérez-Camacho I; Camacho A; Torre-Cisneros J; Rivero A
    Enferm Infecc Microbiol Clin; 2009 Sep; 27 Suppl 1():24-32. PubMed ID: 20172412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Abnormal body fat distribution and type of antiretroviral therapy as predictors of cardiovascular disease risk in HIV-infected patients].
    Ena J; Benito C; Llácer P; Pasquau F; Amador C
    Med Clin (Barc); 2004 May; 122(19):721-6. PubMed ID: 15171905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [First antiretroviral therapy regimen in HIV-infected patients. Durability and factors associated with therapy changes].
    de la Torre J; Santos J; Perea-Milla E; Pérez I; Moreno F; Palacios R; Santamaría S; Del Arco A; Nuño E; Godoy M; Prada JL; Olalla J; Aguilar J; Martos F;
    Enferm Infecc Microbiol Clin; 2008; 26(7):416-22. PubMed ID: 18842236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipodystrophy induced by combination antiretroviral therapy in HIV/AIDS patients: a Belgrade cohort study.
    Dragović G; Danilović D; Dimić A; Jevtović D
    Vojnosanit Pregl; 2014 Aug; 71(8):746-50. PubMed ID: 25181834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dyslipidemia in AIDS patients on highly active antiretroviral therapy.
    Nery MW; Martelli CM; Turchi MD
    Braz J Infect Dis; 2011; 15(2):151-5. PubMed ID: 21503402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic changes associated with antiretroviral therapy in HIV-positive patients.
    Almeida SE; Borges M; Fiegenbaum M; Nunes CC; Rossetti ML
    Rev Saude Publica; 2009 Apr; 43(2):283-90. PubMed ID: 19225696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiretroviral therapy-associated diseases are common in the long-term.
    Lanzafame M; Lattuada E; Zoppini G; Vento S
    AIDS Res Hum Retroviruses; 2011 Sep; 27(9):931-2. PubMed ID: 21182461
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevalence of metabolic syndrome among antiretroviral-naive and antiretroviral-experienced HIV-1 infected Thai adults.
    Jantarapakde J; Phanuphak N; Chaturawit C; Pengnonyang S; Mathajittiphan P; Takamtha P; Dungjun N; Pinyakorn S; Pima W; Prasithsirikul W; Phanuphak P
    AIDS Patient Care STDS; 2014 Jul; 28(7):331-40. PubMed ID: 24914459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.